Decoding Post-Activation Immune Dynamics Beyond Conventional Phenotyping in Cell & Gene Therapy

• Introducing BNX-IFS™, a functional immune interaction profiling platform beyond conventional phenotyping
• Presenting translational and clinical data on dynamic neutrophil–T cell interaction states during immunotherapy and virotherapy
• Discussing real-time immune monitoring for biomarker discovery and next-generation cell and gene therapy development

Speakers:

Tae-Ho Hwang

Chief Technology Officer

Bionoxx